• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响正常人和癌症患者血浆脂蛋白1H NMR谱的一些因素:一种肿瘤脂质检测方法?

Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?

作者信息

Lim H M, Price T B, Marsh J C, Rainey P M, Gore J C, Armitage I M

机构信息

Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06510.

出版信息

Yale J Biol Med. 1991 Jan-Feb;64(1):63-77.

PMID:1897263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2589432/
Abstract

Selected factors have been evaluated in order to determine their influences on the plasma lipoprotein proton NMR spectra of normal and cancer patients. The variables were donor's diet (fasting/non-fasting), temperature and time of sample storage, processing procedure, centrifugation speed, and water pre-saturation time. Plasma samples from fasting individuals that were placed immediately on ice, spun at 1,000 and 3,000 g for 15 minutes, and the proton NMR spectrum acquired with the Carr-Purcell Meiboom-Gill (CPMG) pulse sequence, using a two-second water pre-saturation time, consistently gave reproducible results. Resonances attributed to lactate were minimized under these processing conditions. Centrifugation speed and pre-saturation time did not affect the average line width; however, donor fasting state, processing temperature, and storage time did alter the line width. Most important, blood chemistry analysis revealed an inverse correlation between triglyceride levels and average methyl and methylene line widths. Thus, these factors alone caution against the indiscriminate use of proton NMR spectra to differentiate plasma from normal and cancer patients.

摘要

为了确定某些因素对正常人和癌症患者血浆脂蛋白质子核磁共振谱的影响,对选定的因素进行了评估。这些变量包括供体的饮食(禁食/非禁食)、温度、样品储存时间、处理程序、离心速度和水预饱和时间。来自禁食个体的血浆样本立即置于冰上,以1000和3000克的离心力离心15分钟,并使用两秒的水预饱和时间,通过Carr-Purcell Meiboom-Gill(CPMG)脉冲序列采集质子核磁共振谱,始终能得到可重复的结果。在这些处理条件下,归因于乳酸的共振被最小化。离心速度和预饱和时间不影响平均线宽;然而,供体的禁食状态、处理温度和储存时间确实会改变线宽。最重要的是,血液化学分析显示甘油三酯水平与平均甲基和亚甲基线宽之间呈负相关。因此,仅这些因素就提醒人们不要不加区分地使用质子核磁共振谱来区分正常人和癌症患者的血浆。

相似文献

1
Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?影响正常人和癌症患者血浆脂蛋白1H NMR谱的一些因素:一种肿瘤脂质检测方法?
Yale J Biol Med. 1991 Jan-Feb;64(1):63-77.
2
Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma.甘油三酯水平对人体血浆质子核磁共振波谱中甲基和亚甲基包络线宽的影响。
N Engl J Med. 1989 Jun 1;320(22):1452-7. doi: 10.1056/NEJM198906013202204.
3
Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.恶性肿瘤的检测。血浆的水抑制质子核磁共振波谱分析。
N Engl J Med. 1986 Nov 27;315(22):1369-76. doi: 10.1056/NEJM198611273152201.
4
Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.用于检测恶性肿瘤的质子核磁共振波谱分析评估
Clin Chem. 1988 Mar;34(3):505-11.
5
Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.血浆水抑制质子核磁共振波谱法检测恶性肿瘤的效能不足。
N Engl J Med. 1990 Apr 5;322(14):953-8. doi: 10.1056/NEJM199004053221403.
6
Early changes in the 1H-NMR plasma spectrum in patients following breast surgery.乳腺癌手术后患者血浆1H-NMR谱的早期变化。
Eur J Surg Oncol. 1993 Apr;19(2):115-22.
7
NMR spectroscopy evaluation of plasma "oncolipids" in head and neck cancer.头颈部癌血浆中“肿瘤脂质”的核磁共振光谱评估
Otolaryngol Head Neck Surg. 1990 Jan;102(1):34-40. doi: 10.1177/019459989010200106.
8
[H-NMR spectroscopy of plasma cannot be used for cancer screening].血浆的氢核磁共振光谱法不能用于癌症筛查。
Bull Cancer. 1988;75(8):795-800.
9
Failure of 1H nuclear magnetic resonance spectroscopy of blood plasma to detect malignancy.血浆的氢核磁共振波谱法未能检测出恶性肿瘤。
J Clin Oncol. 1990 May;8(5):906-10. doi: 10.1200/JCO.1990.8.5.906.
10
Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancy.恶性肿瘤中血浆脂蛋白的质子核磁共振波谱分析
Acta Oncol. 1988;27(5):479-82. doi: 10.3109/02841868809093574.

本文引用的文献

1
Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal.兔感染布氏布氏锥虫所致高甘油三酯血症:甘油三酯清除缺陷的作用
Mol Biochem Parasitol. 1980 Oct;2(1):31-8. doi: 10.1016/0166-6851(80)90046-8.
2
Plasma lipid alterations in leukemia and lymphoma.
Am J Med. 1982 May;72(5):775-82. doi: 10.1016/0002-9343(82)90543-5.
3
High-resolution proton nuclear magnetic resonance analysis of metastatic cancer cells.转移性癌细胞的高分辨率质子核磁共振分析。
Science. 1984 Dec 21;226(4681):1415-8. doi: 10.1126/science.6505699.
4
Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.恶病质素的纯化,一种由内毒素诱导的RAW 264.7细胞分泌的脂蛋白脂肪酶抑制激素。
J Exp Med. 1985 May 1;161(5):984-95. doi: 10.1084/jem.161.5.984.
5
Nuclear magnetic resonance studies of lipoproteins.脂蛋白的核磁共振研究。
Methods Enzymol. 1986;128:472-515. doi: 10.1016/0076-6879(86)28088-x.
6
Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.恶性肿瘤的检测:血浆的水抑制质子核磁共振波谱分析
Magn Reson Med. 1987 Oct;5(4):395-7. doi: 10.1002/mrm.1910050414.
7
An improved method for the detection of malignancy by proton NMR spectroscopy of plasma.一种通过血浆质子核磁共振波谱检测恶性肿瘤的改进方法。
Biochem Biophys Res Commun. 1987 Jun 30;145(3):1397-403. doi: 10.1016/0006-291x(87)91593-2.
8
1H NMR studies of human blood plasma. Assignment of resonances for lipoproteins.人血浆的核磁共振氢谱研究。脂蛋白共振峰的归属
FEBS Lett. 1987 Jul 13;219(1):239-43. doi: 10.1016/0014-5793(87)81224-3.
9
Detection of malignant tumors by nuclear magnetic resonance spectroscopy of plasma.通过血浆核磁共振波谱法检测恶性肿瘤
N Engl J Med. 1987 May 28;316(22):1411-5. doi: 10.1056/NEJM198705283162214.
10
[Nuclear magnetic resonance of plasma? A method for the diagnostic and therapeutic control of cancer?].[等离子体的核磁共振?一种癌症诊断与治疗控制的方法?]
Dtsch Med Wochenschr. 1988 Apr 29;113(17):705-6.